| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aminoglycosides: old friend…new foe?
|
Simmonds, N.J.
|
|
2016
|
15 |
4 |
p. 411-412
2 p.
|
article
|
| 2 |
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
|
Flume, Patrick A.
|
|
2016
|
15 |
4 |
p. 495-502
8 p.
|
article
|
| 3 |
Beyond the lungs: The new GI frontier
|
Freedman, Steven D.
|
|
2016
|
15 |
4 |
p. 409-410
2 p.
|
article
|
| 4 |
Bilateral midshaft femoral fractures in an adolescent baseball player
|
Ju, D.G.
|
|
2016
|
15 |
4 |
p. e41-e43
nvt p.
|
article
|
| 5 |
Bronchial epithelial cell lines and primary nasal epithelial cells from cystic fibrosis respond differently to cigarette smoke exposure
|
Williams, Mark Thomas Shaw
|
|
2016
|
15 |
4 |
p. 467-472
6 p.
|
article
|
| 6 |
CF end point commentary
|
Durmowicz, Anthony G.
|
|
2016
|
15 |
4 |
p. 424-
1 p.
|
article
|
| 7 |
Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis
|
Niccum, David E.
|
|
2016
|
15 |
4 |
p. 548-553
6 p.
|
article
|
| 8 |
Diagnostic accuracy and distress associated with oropharyngeal suction in cystic fibrosis
|
Doumit, Michael
|
|
2016
|
15 |
4 |
p. 473-478
6 p.
|
article
|
| 9 |
Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates
|
Amoureux, Lucie
|
|
2016
|
15 |
4 |
p. 486-494
9 p.
|
article
|
| 10 |
d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models
|
Fox, Daniel J.
|
|
2016
|
15 |
4 |
p. 518-530
13 p.
|
article
|
| 11 |
Editorial Board
|
|
|
2016
|
15 |
4 |
p. ii-
1 p.
|
article
|
| 12 |
Efficacy measures for clinical trials: A review series
|
Flume, Patrick A.
|
|
2016
|
15 |
4 |
p. 415-
1 p.
|
article
|
| 13 |
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel
|
Pesce, Emanuela
|
|
2016
|
15 |
4 |
p. 425-435
11 p.
|
article
|
| 14 |
Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis
|
Hauser, Bruno
|
|
2016
|
15 |
4 |
p. 540-547
8 p.
|
article
|
| 15 |
Highlighting the impact of cascade carrier testing in cystic fibrosis families
|
Duguépéroux, Ingrid
|
|
2016
|
15 |
4 |
p. 452-459
8 p.
|
article
|
| 16 |
International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome
|
Munck, Anne
|
|
2016
|
15 |
4 |
p. 531-539
9 p.
|
article
|
| 17 |
Newborn bloodspot screening for cystic fibrosis: What do antenatal and postnatal women know about cystic fibrosis?
|
Fitzgerald, C.
|
|
2016
|
15 |
4 |
p. 436-442
7 p.
|
article
|
| 18 |
Newborn screening and population carrier screening for cystic fibrosis: Two ends of the same rope
|
Massie, John
|
|
2016
|
15 |
4 |
p. 407-408
2 p.
|
article
|
| 19 |
Newborn screening for cystic fibrosis — The parent perspective
|
Rueegg, Corina S.
|
|
2016
|
15 |
4 |
p. 443-451
9 p.
|
article
|
| 20 |
News
|
|
|
2016
|
15 |
4 |
p. 413-414
2 p.
|
article
|
| 21 |
Physiologic endpoints for clinical studies for cystic fibrosis
|
Stanojevic, Sanja
|
|
2016
|
15 |
4 |
p. 416-423
8 p.
|
article
|
| 22 |
The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening
|
Stafler, Patrick
|
|
2016
|
15 |
4 |
p. 460-466
7 p.
|
article
|
| 23 |
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
|
Prayle, A.P.
|
|
2016
|
15 |
4 |
p. 510-517
8 p.
|
article
|
| 24 |
Tracheal diverticula in cystic fibrosis—A potentially important underreported finding on chest CT
|
Gayer, Gabriela
|
|
2016
|
15 |
4 |
p. 503-509
7 p.
|
article
|
| 25 |
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy
|
Fitch, G.
|
|
2016
|
15 |
4 |
p. e35-e40
nvt p.
|
article
|
| 26 |
Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK
|
Coward, Amy
|
|
2016
|
15 |
4 |
p. 479-485
7 p.
|
article
|
Journal description